Variables | Normal | CHD Alone | Sarcopenia Alone | Co-occurring | P-value |
---|---|---|---|---|---|
 | (n = 635) | (n = 174) | (n = 63) | (n = 25) |  |
Age (y) | 66.0 ± 5.5 | 67.3 ± 5.6a | 72.4 ± 6.5a,b | 71.4 ± 6.3a,b | <0.001 |
Sex (Male) | 314(49.4) | 48(27.6)a | 19(30.2)a | 5(20.0)a | <0.001 |
BMI (kg/m2) | 25.39 ± 3.30 | 26.02 ± 3.64a | 22.68 ± 3.11a,b | 22.51 ± 2.71a,b | <0.001 |
Grip strength (kg) | 26.51 ± 9.53 | 23.32 ± 9.25a | 16.04 ± 6.32a,b | 16.52 ± 8.03a,b | <0.001 |
SMI (kg/m2) | 7.31 ± 1.01 | 7.08 ± 1.09 | 5.43 ± 0.91a,b | 5.43 ± 0.56a,b | <0.001 |
Gait speed (m/s) | 1.01 ± 0.17 | 0.96 ± 0.16a | 0.85 ± 0.19a,b | 0.77 ± 0.22a,b | <0.001 |
IPAQ (Met/wk) | 2142(924,4147) | 1848(693,4186) | 2079(1386,3066) | 1038(0,4697) | 0.732 |
Widowed (%) | 76(12.0) | 26(14.9)a | 21(33.3)b | 6(24.0) | 0.001 |
Living alone (%) | 90(14.2) | 21(12.1) | 16(25.4) | 5(20.0) | 0.253 |
Illiteracy (%) | 152(24.0) | 45(25.9) | 28(44.4)a | 7(28.0) | 0.006 |
Farming (%) | 559(88.2) | 156(89.7) | 57(90.5) | 22(88.0) | 0.911 |
Fall history (%) | 84(13.2) | 25(14.4) | 12(19.0) | 8(32.0) | 0.044 |
Drinking (%) | 90(14.2) | 12(6.9)a | 8(12.7) | 0(0.0) | 0.002 |
Smoking (%) | 180(28.4) | 47(27.2) | 22(34.9) | 10(40.0) | 0.326 |
MNA-SF | 13.06 ± 1.12 | 13.15 ± 0.90 | 12.19 ± 1.74a,b | 12.08 ± 1.58a,b | < 0.001 |
Sleep Duration (h) | 7.87 ± 1.32 | 8.12 ± 1.47 | 8.39 ± 1.30a | 8.36 ± 2.33 | 0.005 |
Sleep quality (%) | Â | Â | Â | Â | 0.003 |
 Very well | 339(53.4) | 65(37.6)a | 29(46.0) | 7(28.0) |  |
 Good | 186(29.3) | 61(35.3) | 20(31.7) | 9(36.0) |  |
 Not enough | 56(8.5) | 20(11.6) | 6(9.5) | 6(24.0) |  |
 Very poor | 54(8.5) | 27(15.6) | 8(12.7) | 3(12.0) |  |
Medicine use (%) | |||||
  Hypotensive drugs | 222(35.0) | 88(50.6)a | 21(33.3)b | 10(40.0) | < 0.001 |
  Hypoglycemic drugs | 41(6.5) | 27(15.5)a | 4(6.3)b | 3(12.0) | < 0.001 |
  Lipid-lowering drugs | 78(12.3) | 19(10.9) | 2(3.2) | 3(12.0) | 0.237 |
  Cardiovascular drugs | 2(0.3) | 102(58.6)a | 3(4.8)b | 11(44.0)a,c | < 0.001 |
  Gastrointestinal drugs | 16(2.5) | 3(1.7) | 3(4.8) | 1(4.0) | 0.382 |
  Sleep drugs | 34(5.4) | 24(13.8)a | 7(11.1) | 5(20.0)a | <0.001 |
Chronic conditions (%) | |||||
 Diabetes | 66(10.4) | 30(17.2) | 14(22.2) | 6(24.0)a,b | 0.003 |
 Hypertension | 320(50.4) | 116(66.7)a | 29(46.0)b | 17(68.0) | < 0.001 |
 Hyperlipidemia | 236(37.2) | 80(46.0) | 11(17.5)a,b | 11(44.0) | 0.001 |
 Stroke | 36(5.7) | 15(8.6) | 6(9.5) | 3(12.0) | 0.257 |
 Kidney disease | 24(3.8) | 10(5.7) | 2(3.2) | 1(4.0) | 0.684 |
 Hepatic disease | 11(1.7) | 2(1.1) | 0(0.0) | 2(8.0) | 0.059 |
 Biliary tract disease | 19(3.0) | 10(5.7) | 4(6.3) | 2(8.0) | 0.164 |
 Peptic ulcer | 22(3.5) | 12(6.9) | 4(6.3) | 2(8.0) | 0.160 |
 Osteoarthritis | 82(12.9) | 33(19.0) | 8(12.7) | 4(16.0) | 0.231 |
 Parkinson disease | 2(0.3) | 1(0.6) | 0(0.0) | 1(4.0) | 0.316 |
 Gout | 3(0.5) | 2(1.1) | 0(0.0) | 0(0.0) | 0.642 |
 CCI | 2.45 ± 0.76 | 3.63 ± 0.76a | 3.24 ± 0.88a,b | 4.32 ± 1.31a,b,c | < 0.001 |